Amsterdam-based Nico.Lab has launched an update of its clinical decision-support tool, StrokeViewer.
The release of the tool follows a successful funding round of 13 million Australian dollars (8.3 million euros) earlier this year. The company also signed AI Advance to distribute StrokeViewer in Australia and New Zealand.
The new mobile application for StrokeViewer includes artificial intelligence algorithms and features for physicians diagnosing stroke patients. It includes three CE-marked algorithms for collateral assessment, automated perfusion analysis, and Alberta Stroke Program Early CT Score (ASPECTS).
